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Abstract
Introduction and hypothesis The aim of the study was to
compare the efficacy and safety of transvaginal trocar-
guided polypropylene mesh insertion with traditional
colporrhaphy for treatment of anterior vaginal wall prolapse.
Methods This is a randomized controlled trial in which wom-
en with advanced anterior vaginal wall prolapse, at least stage
II with Ba≥+1 cm according to the Pelvic Organ Prolapse
Quantification (POP-Q) classification, were randomly
assigned to have either anterior colporrhaphy (n=39) or repair
using trocar-guided transvaginal mesh (n=40). The primary
outcome was objective cure rate of the anterior compartment
(point Ba) assessed at the 12-month follow-up visit, with stages
0 and I defined as anatomical success. Secondary outcomes
included quantification of other vaginal compartments (POP-Q
points), comparison of quality of life by the prolapse quality of
life (P-QOL) questionnaire, and complication rate between the
groups after 1 year. Study power was fixed as 80 % with 5 %
cutoff point (p<0.05) for statistical significance.
Results The groups were similar regarding demographic and
clinical preoperative parameters. Anatomical success rates for
colporrhaphy and repair with mesh placement groups were
56.4 vs 82.5% (95% confidence interval 0.068–0.54), respec-
tively, and the difference between the groups was statistically
significant (p=0.018). Similar total complication rates were
observed in both groups, with tape exposure observed in 5 %
of the patients. There was a significant improvement in all P-
QOL domains as a result of both procedures (p<0.001), but
they were not distinct between groups (p>0.05).
Conclusions Trocar-guided transvaginal synthetic mesh for
advanced anterior POP repair is associated with a higher
anatomical success rate for the anterior compartment
compared with traditional colporrhaphy. Quality of life equally
improved after both techniques. However, the trial failed to
detect differences in P-QOL scores and complication rates
between the groups.
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Introduction
It is believed that the incidence of pelvic organ prolapse
(POP) will substantially increase in the next decades with
the fast growth of the elderly population in developed coun-
tries [1]. It is estimated that 41 % of women aged 50–79 will
present with some degree of POP at, with 35 % related to the
anterior vaginal wall [2]. Recently, efforts have been made
to establish the most appropriate surgical procedure to repair
POP. The investigations are fundamentally based on the
usage of synthetic prostheses in order to reestablish the
pelvic floor anatomy and function as an alternative to stan-
dard native tissue repair [3].
The anterior vaginal wall is the most common compart-
ment to prolapse and the major focus of the discussion about
the potential benefits of augmentation with synthetic meshes
[2, 4]. The last systematic review of the recent literature
concluded that the use of meshes to repair the anterior
compartment is associated with a better anatomical success
C. A. Delroy (*) :R. de A. Castro :M. M. Dias :
P. C. Feldner Jr. :M. A. T. Bortolini :M. J. B. C. Girão :
M. G. F. Sartori
Sector of Urogynecology and Vaginal Surgery, Department of
Gynecology, Federal University of São Paulo, Rua Joaquim
Floriano, 871 cj 92,
São Paulo, SP, Brazil 04534-000
e-mail: delroy@terra.com.br
Int Urogynecol J (2013) 24:1899–1907
DOI 10.1007/s00192-013-2092-0
rate when compared to anterior colporrhaphy (AC), al-
though the authors highlighted the need for additional
high-quality studies including both patient-reported and
clinician-observed outcomes to support the use of mesh
and to be able to verify its efficacy in the long term [5].
Even though rarely evidence-based [5], trocar-guided
mesh kits have been increasingly used in POP surgery and
involve the use of metal trocars for placement of a synthetic
mesh, standardized in shape and size to support the vaginal
walls. Nazca TC™ (Promedon, Córdoba, Argentina) is an
example of a device designed to repair anterior vaginal wall
prolapse. Palma et al. have published initial results of its
usage. The authors prospectively analyzed a cohort of 104
patients and observed improved objective and subjective
parameters after 1 year of follow-up [6]. The next logical
step in research should be to confront this new technique
with the current standard procedure.
In view of that, we developed this randomized controlled
trial (RCT) intended to evaluate the efficacy and safety of
both AC and the use of transvaginal synthetic mesh (Nazca
TC™) to repair advanced anterior vaginal wall prolapse. We
hypothesized that anterior repair by using the Nazca TC™
kit is not inferior to traditional colporrhaphy in 1-year
follow-up time. We aimed to analyze and compare the
objective success rate in the anterior compartment using
point Ba measurements. Secondary endpoints were subjec-
tive improvement (condition-specific quality of life ques-
tionnaire), complication rate, and descent of all vaginal
compartments [Pelvic Organ Prolapse Quantification
(POP-Q)] after both surgical techniques.
Patients and methods
The study was designed as a non-inferiority RCT comparing
efficacy and complication rates of AC and trocar-guided
transvaginal polypropylene mesh insertion (MESH) to repair
advanced anterior vaginal wall prolapse. This study was
conducted at the Sector of Urogynecology and Vaginal Sur-
gery, Federal University of São Paulo, Brazil, a tertiary referral
academic center, after the approval of the local Ethics Com-
mittee and registration at ClinicalTrials.gov (FDA) under pro-
tocol NCT00676325. The study was funded by the Federal
University of São Paulo and Hospital São Paulo. Promedon
contributed by donating the kits to be evaluated under the
research protocol performed by urogynecology staff and fel-
lows during regular activities, as part of their training pro-
gram. No unrestricted research grant was provided.
From January 2007 to January 2009, women were assessed
for eligibility by all authors during regular activities in the
clinic. From among them, consecutive women presentingwith
anterior POP at least stage II beyond the hymen with point Ba
equal to or greater than +1 according to the POP-Q
classification [7] were initially enrolled as candidates for the
study. We included patients presenting with either primary or
recurrent POP cases, with the anterior compartment being the
most prominent. We excluded women with malignant urogen-
ital disease or previous pelvic radiotherapy, acute genitouri-
nary infection, connective tissue disorders, systemic
glucocorticoid treatment, insulin-treated diabetes, or clinical
contraindications to a surgical procedure.
After being instructed and providing written informed con-
sent to the first author, women who agreed to participate in the
study were assigned to have either AC or MESH. The first
author conducted the enrollment and randomization. Block
randomization assigned in the ratio of 1:1 was done using a
computerized random number generator using the program
SPSS® (V17.0) at themoment of inclusion. A secretary blinded
to the patients’ history and with no contact with the patients
created envelopes that contained the allocation according to the
order randomized by the computer. Oncewomenwere included
in the trial, the intraoperative and postoperative protocol forms
as well as the envelopes with the allocation groupwere attached
in the patients’ files. So the surgeon was only aware of the
allocation group in the operating room.
Sample size was calculated by the Diman® computer pro-
gram on the basis of rates of anterior compartment objective
measurements (point Ba) described in the literature: recurrence
rate after AC (POP-Q≥stage II) ranging between 20 and 70 %
and after synthetic mesh surgery in the anterior compartment
ranging between 3 and 13 % [8–14]. Anatomical success rate
for the anterior compartment was considered as 68 % for AC
according to our center’s experience (data not published) and
as 85 % for mesh repair, in order to evaluate the best scenario
for AC and the worst scenario for mesh repair outcomes (17 %
difference between them). We estimated that 35 subjects per
group provides 80 % power to our model, with 0.05 signifi-
cance level, and anticipating a 10 % loss to follow-up and/or
dropout rate over the period of the study [15].
Statistical analyses were performed using the program
SPSS® (V19.0). Descriptive analysis was presented in ab-
solute numbers, mean and standard deviation for quantita-
tive variables, while percentage was used for qualitative
variables. Student’s t and Mann–Whitney tests were used
to compare continuous variables between the groups. Chi-
square and Fisher’s tests were used for evaluation of nom-
inal variables. Analysis of variance (ANOVA) was
performed for comparison of POP measurement between
the study groups at pre- and postoperative time points. Per
protocol, intention to treat, and number needed to treat
analyses were planned. We considered a cutoff point of p<
0.05 for statistical significance in all analyses.
The study aimed to determine and compare the efficacy
and safety of both surgical techniques after 1 year. The
primary outcome was the objective evaluation of anatomical
success, defined as anterior vaginal wall at stages 0 and I
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(Ba<−1) according to the POP-Q system. Secondary out-
comes were the comparison of intra- and postoperative com-
plications and the quality of life related to POP using the
validated condition-specific prolapse quality of life (P-QOL)
questionnaire. Total scores for each P-QOL domain range
from 0 to 100 and are used to measure the severity of the
POP symptoms [16]. In addition, we evaluated the other
anatomical compartments using POP-Q measurements.
The pre- and postoperative protocol included: interview,
urogynecological history, gynecological and general physi-
cal examination, urodynamics study when needed, blood
test and urinalysis, and quality of life assessment using the
P-QOL questionnaire validated for the Portuguese language
[17]. POP symptoms such as vaginal “bulge,” pelvic pain,
and sensation of heaviness were individually assessed using
specific questions contained in the P-QOL. We considered
as POP-positive symptoms if the patients answered “yes”
(“slightly/a little,” “moderately,” or “a lot”) to at least one of
the questions 3e-h. Dyspareunia was assessed by the unique
question: “Do you have pain during intercourse?” and con-
sidered positive if the patient answered “yes.”
The patients were examined in the lying position with a full
bladder and asked to perform the Valsalva maneuver. The
descensus of the vaginal compartments was measured at the
maximum straining point using a centimeter scale ruler. Total
vaginal length was measured at rest under POP reduction with
a vaginal speculum. Afterward, a straining examination in the
standing position confirmed the full extent of the POP.
The surgeries were performed from February 2007 to De-
cember 2009. The AC procedure started with vaginal infiltra-
tion with a lidocaine and 2 % epinephrine solution diluted 1:1
in a total of 40 ml. A longitudinal midline incision of the
vaginal mucosa from 2 cm of the urethral meatus to the uterine
cervix or vaginal vault was performed and dissected away
from the pubocervical fascia laterally and bilaterally. Purse
string sutures were used to plicate the fascia with Vicryl® 0,
followed by vaginal mucosa trimming and midline closure
with interrupted suture using Vicryl® 2–0.
For the transvaginal mesh insertion, we used the trocar-
guided kit Nazca TC™ (Promedon, Córdoba, Argentina)
designed for anterior POP repair. It consists of a type I mono-
filament and macroporous polypropylene mesh. The set also
contains one prepubic and two transobturator needles with
removable, ergonomic handles. The surgical technique was
previously described [6]. Briefly, after vaginal infiltration with
lidocaine and vasoconstrictor solution, two 5-mm suprapubic
incisions were made 3 cm apart. A full thickness vaginal
incision from the midurethra towards the uterine cervix or
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Fig. 1 CONSORT diagram of
participants. Note that data are
available from the total cohort
of randomized patients at the 1-
year follow-up
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vault was made allowing proper vaginal dissection extended
towards the ascending branch of the ischium and inferior
aspect of the pubic bone. Next, the prepubic needle was
introduced through the vaginal incision and directed towards
the corresponding suprapubic incision, and then the mesh
arms were delivered bilaterally. The transobturator needle
was inserted at the genitofemoral fold on an outside-in direc-
tion exiting closest to the ischial spine in the vaginal opening.
Next, the transobturator arm was connected to the needle and
was brought through the bilateral genitofemoral skin incision
in a reverse fashion. Sutures were placed on the body of the
mesh to the remnants of the cardinal ligament or the
Table 1 Pre- and postoperative
demographic and clinical data of
the study groups
Student’s t test, Mann–Whitney
test, Pearson’s chi-square test,
and Fisher’s test. A significant
difference is indicated by *p<
0.05
SUI stress urinary incontinence,
UTI urinary tract infection
Variable AC (n=39) MESH (n=40) p value
Mean age, years (±SD) 59.6 (±10) 62.1 (±8.3) 0.231
Mean BMI, kg/m2 (±SD) 27.3 (±3.7) 27.6 (±4.7) 0.743
Mean vaginal parity (range) 4 (2–6) 5.3 (0.7–9.9) 0.314
Previous POP surgery, n (%) 13 (33.3 %) 8 (20 %) 0.180
Previous hysterectomy, n (%) 3 (7.6 %) 1 (2.5 %) 0.099
Previous SUI surgery, n (%) 12 (30.8 %) 8 (20 %) 0.271
Menopausal status, n (%)
Premenopausal 7 (17.9 %) 2 (5.0 %) 0.087
Postmenopausal 32 (82.1 %) 38 (95 %)
Anterior POP-Q stage, n (%)
II 16 (41.0 %) 8 (20 %) 0.099
III 20 (51.3 %) 26 (65.0 %)
IV 3 (7.7 %) 6 (15.0 %)
Posterior POP-Q stage, n (%)
0/I 9 (23 %) 18 (45 %) 0.083
II 28 (71.8 %) 20 (50 %)
III 2 (5.1 %) 2 (5 %)
Apical POP-Q stage, n (%)
0/I 31 (79.5 %) 28 (70 %) 0.07
II 3 (7.7 %) 9 (22.5 %)
III 5 (12.8 %) 3 (7.5 %)
Concomitant surgical procedures, n (%)
Vaginal hysterectomy/trachelectomy 14 (35.9 %) 8 (20 %) 0.115
Enterocele repair 3 (7.6 %) 4 (10 %) 0.91
Site-specific posterior colporrhaphy 28 (100 %) 17 (42.5 %) 0.83
Sacrospinal fixation 0 1 (2.5 %) 0.97
Mean operative time, min (±SD) 46 (±28.1) 99.1 (±35.8) <0.001*
Mean length of hospitalization, days (±SD) 3.3 (±1.2) 3.2 (±2.6) 0.85
Postoperative adverse events, n (%)
Intraoperative
Increased bleeding 12 (30.8 %) 18 (45.0 %) 0.193
Blood transfusion 1 (5.1 %) 2 (5 %) 1.00
Bladder perforation 0 0 –
Urethral perforation 0 1 (2.5 %) 0.99
Postoperative 0 0 –
Tape exposure 0 2 (5 %) 0.76
Wound infection 0 0 –
Urinary retention 2 (5.1 %) 1 (2.5 %) 0.88
Voiding dysfunction 0 1 (2.5 %) 0.99
UTI 5 (13.8 %) 8 (20 %) 0.34
Dyspareunia 4 (10.2 %) 2 (5 %) 0.78
Transient thigh numbness 0 1 (2.5 %) 0.99
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pericervical ring using polypropylene sutures to avoid apical
cystocele recurrence. All four arms were gently pulled in a
tension-free manner and trimmed if needed. The vaginal wall
was closed using the Montgomery overlapping technique to
avoid superposition of the suture line on the mesh with
interrupted sutures using Vicryl® 2–0.
All procedures were conducted under spinal anesthesia.
Cystoscopy was performed in the operating room at the sur-
geon’s discretion. All patients received cefazolin (2 g) and
metronidazole (500 mg) as antibiotic prophylaxis. The pro-
cedures were performed by experienced surgeons (CAD,
MMD, and RAC). Patients had their 14 F Foley vesical cath-
eter and vaginal tampon removed on the first postoperative day
(PO #1). A blood test was performed 24 h after the procedure
to be able to detect an eventual drop in hemoglobin. The
discharge occurred according to individual clinical conditions.
A social assistance worker routinely contacted the partic-
ipants monthly by phone call, reinforcing the adherence to
the treatment. The follow-up appointments occurred at day 7
and 1, 3, 6, and 12 months after surgery. In order to decrease
examiner interference in our results, postoperative evalua-
tions were conducted by a urogynecology physician blinded
to the surgical procedure. On those occasions, anamnesis
and physical examination with POP quantification were
performed. Urinalysis was ordered if the patients presented
with irritative urinary symptoms to rule out urinary tract
infection. We considered urinary tract infection related to
surgery if it occurred up to 30 days after surgery. Urinary
retention and voiding dysfunction were considered if the
patient was unable to void properly (post-void residual>
150 ml) at PO #1. Increased bleeding was characterized by
a rate of hemoglobin drop equal to or greater than 2.0 g/dl
24 h after the procedure. The impact of the surgery on
quality of life was assessed by P-QOL at the time of the 1-
year follow-up.
Results
During the study period, 355 consecutive women were
assessed for eligibility. Eighty women met the inclusion
criteria and were initially enrolled. From among them, 79
agreed to participate in the study with 39 (49.4 %) random-
ized to receive AC and 40 (50.6 %) MESH. All patients
returned for follow-up at 1 year and had all protocol steps
completed (Fig. 1).
Demographic and clinical pre- and postoperative param-
eters are shown in Table 1. The groups were homogeneous
regarding age, with the majority in the postmenopausal
phase, as well as body mass index (BMI), vaginal parity,
and previous pelvic surgeries. In the AC and MESH groups,
30.8 and 20 % were recurrent POP cases, respectively. Both
groups were also similar in relation to preoperative POP
stage quantification for all different compartments. Of the
patients, 20/39 (51.3 %) and 26/40 (65 %) presented with
stage III anterior compartment prolapse in the AC and
MESH groups, respectively.
With regard to surgical procedures, the mean operative
time was significantly longer in the MESH group (99.1 min)
compared to the AC group (46 min) (p<0.001). However,
the length of hospitalization was not different between them.
As expected, concomitant other pelvic reconstructive pro-
cedures were relatively common in both groups (p>0.05).
Per protocol and intention to treat analyses evidenced that
around 82.5 % of the patients from the MESH group and
56.4 % from the AC group met the strict criteria for anatomical
success in the anterior compartment (95 % confidence interval
0.068–0.54) at the 1-year follow-up, and this difference
showed statistical significance (p=0.018) (Fig. 2). The mean
preoperative point Ba was +2.22 cm in the AC patients and +
2.77 cm in the patients that received MESH; mean postopera-
tive values were −1.44 and −1.97 cm, respectively (Table 2).
The number needed to treat (NNT) was calculated as 4.
As shown in Table 2, we observed higher measures of
POP-Q points in the postoperative compared to the preop-
erative time in both groups (p<0.001 for all compartments).
Some analyses showed an interaction effect between the
measurements in the two time points (pre- and postopera-
tive) and the two groups. In those situations, an ANOVA test
was required and evidenced an additional statistically sig-
nificant difference in the points gh, Ap, Bp, and D, favoring
the AC group for the points Ap and Bp (p<0.001 for both)
and favoring the MESH group for gh and D (p=0.005 and
0.001, respectively). Similar measurements were observed
for Aa, C, and tvl between the groups.
By evaluating specific questions from the P-QOL ques-
tionnaire related to POP symptoms, we could find evidence
that ten (26 %) patients from the AC group reported at least
one bothersome POP symptom 1 year after surgery. Among
56.4%
43.59%
82.5%
17.50%
0.0%
25.0%
50.0%
75.0%
100.0%
AC MESH
success failure
*
Fig. 2 Anatomical success defined as point Ba<−1. Values are given
in % of patients that met the cure criteria from each group. Pearson’s
chi-square test. A significant difference is indicated by *p<0.05
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them, eight have received further revision with mesh repair,
and two opted for another AC. On the other hand, two (5 %)
patients from the MESH group were symptomatic after
1 year but did not want another surgical procedure. Women
presenting with recurrent POP symptoms had POP stage II
(Ba=0 or +1) during physical examination.
Intra- and postoperative total complication rates were
30.8 % (12/39) and 45 % (18/40) for the AC and MESH
groups, respectively. Adverse events are described in
Table 1. We had increased bleeding (hemoglobin drop<
2 g/dl) in two patients from the MESH group and one from
the AC group, with no blood transfusion required. Bladder
perforation due to digital dissection occurred in one surgery
using mesh, detected and repaired intraoperatively, with no
ureteral damage by cystoscopy. This woman had an indwell-
ing catheter for 14 days, without developing any further
voiding dysfunction. Postoperative complications were sim-
ilar in both groups. Of 39 patients in the AC group, 19 were
sexually active prior to surgery and also after the procedure.
Among them, four reported dyspareunia at the 1-year
follow-up (21 %). Regarding the MESH group, 21/40 wom-
en were sexually active before the operation, and 2 of them
described pain during intercourse after the surgery (10 %).
In addition, two patients resumed their sexual life after
Table 2 Anatomical objective measurements at the 1-year follow-up
AC MESH
Point Moment Interaction n Mean SD n Mean SD pb value
Pre-op 39 1.7 1.0 40 2.0 0.8 0.769
Aa Post-op pi=0.114 39 −1.7 0.9 40 −1.9 1.0
pa<0.001* pa<0.001*
Pre-op 39 2.3 1.5 40 2.8 1.3 0.072
Ba Post-op pi=0.004* 39 −1.4 1.0 40 −1.9 1.1 0.018*
pa<0.001* pa<0.001*
Pre-op 39 −3.4 2.8 40 −3.2 2.0 0.615
C Post-op pi=0.742 39 −4.8 1.2 40 −4.1 1.6
pa <0.001* pa <0.001*
Pre-op 39 4.3 1.0 40 5.0 1.2 0.005*
gh Post-op pi=0.909 39 2.8 0.9 40 3.3 1.0
pa<0.001* pa<0.001*
Pre-op 39 2.7 0.7 40 3.0 0.9 0.119
pb Post-op pi=0.013* 39 3.6 0.8 40 3.5 0.8 0.232
pa<0.001* pa<0.001*
Pre-op 39 7.1 0.8 40 6.8 1.0 0.31
tvl Post-op pi=0.106 39 7.2 1.2 40 6.8 1.3
pa<0.001* pa<0.001*
Pre-op 39 −0.6 1.5 40 −1.2 1.2 0.071
Ap Post-op pi=<0.001* 39 −2.4 0.6 40 −1.5 1.2 < 0.001*
pa<0.001* pa=0.318
Pre-op 39 −1.0 1.0 40 −1.4 0.9 0.059
Bp Post-op pi=<0.001* 39 −2.4 0.7 40 −1.5 1.2 < 0.001*
pa <0.001* pa=0.636
Pre-op 38 −5.5 1.9 33 −4.7 1.3 0.001*
D Post-op pi=0.556 24 −6.3 0.8 24 −5.6 1.3
pa<0.001* pa<0.001*
gh genital hiatus, pb perineal body, tvl total vaginal length
ANOVA test: pa values obtained from intragroup analyses according to the time (preoperative mean point versus postoperative mean point); pb
values obtained from intergroup postoperative analyses (AC postoperative mean point versus MESH postoperative mean point); pi values obtained
from the analyses of interaction between groups and moments (four mean points: preoperative AC versus postoperative AC versus preoperative
MESH versus postoperative MESH). Significant difference is indicated by *p<0.05. Note that all point measurements of both groups significantly
improved in the postoperative time when compared to preoperative status. Note that a positive interaction factor was present in the analyses of
points Ba, PB, Ap, and Bp. Note that final analyses showed significantly different values for the anatomical points Ba, gh, Ap, Bp, and D between
the study groups
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anterior repair with mesh augmentation. Mesh extrusion was
noted in 2/40 (5 %). They were smaller than 1 cm and
asymptomatic. After failure of conservative local estrogen
therapy for 30 days, the portion of the extruded meshes were
trimmed under local anesthesia in the clinic.
Subjective results by the analyses of the P-QOL ques-
tionnaire showed improvement in all nine domains of the
questionnaire 1 year after repair with either AC or MESH
(p<0.001 for all). When compared between the techniques,
the domain scores were not different between the groups,
suggesting that the efficacy of both procedures was equal
according to the patients’ reports (Table 3).
Discussion
A recent systematic review article acknowledges that mesh
insertion may have a role in reconstructive pelvic surgery in
women [18]. The last meta-analysis of some high-quality
RCTs supports the use of transvaginal synthetic meshes over
native tissues for anterior vaginal wall prolapse repair consid-
ering anatomical results [5]. On the other hand, there are still
relevant questions raised by the scientific community about its
utilization due to potential risks inherent to the procedure as
well as which patients would benefit frommesh augmentation
[18–20]. However, there seems to be a consensus that addi-
tional comparative studies are required to clarify those issues.
Very few studies have described the results of trocar-guided
commercial mesh kits for anterior compartment prolapse un-
der the auspices of an RCT [11, 14, 20], whichmotivated us to
perform this study evaluating Nazca TC™. Our results are in
accordance with the majority of previous studies involving
polypropylene meshes in general [9, 11, 13, 21] and have
shown that the anatomical success rate is higher by using
mesh, with no difference regarding quality of life related to
POP and complication rates when AC was compared to mesh
augmentation in advanced anterior POP at the 1-year follow-
up. However, it is difficult to compare the findings of each
study with other trials owing to variations in the surgical
procedures, implant materials, outcomes measurements, and
Table 3 Comparison between
the study groups of pre- and 1-
year postoperative P-QOL
scores
Values are given as absolute
numbers. ANOVA test. A sig-
nificant difference is indicated
by *p<0.05. Note that all ques-
tionnaire domains of both
groups significantly improved in
the postoperative time when
compared to preoperative status.
Note that final analyses showed
no difference in P-QOL scores
between the study groups
P-QOL questionnaire domains AC MESH p value
General health perceptions
Pre-op 42.2±21.2 46.79±22.33 0.38
Post-op 24.1±10.5 26.28±21.30 0.98
Prolapse impact
Pre-op 79.3±30.0 74.35±33.41 0.33
Post-op 3.4±10.3 3.41±15.06 0.70
Role limitation
Pre-op 64.9±25.7 45.72±39.35 0.78
Post-op 2.8±15.4 0.0±0.0 0.33
Physical limitation
Pre-op 63.7±25.2 55.55±8.64 0.80
Post-op 2.8±15.4 2.13±7.53 0.46
Social limitation
Pre-op 34.8±20.0 36.60±13.52 0.09
Post-op 0.0±0.0 0.56±13.03 –
Personal relationship
Pre-op 54.1±34.4 27.77±12.96 0.61
Post-op 0.0±0.0 0.0±0.0 0.35
Emotions
Pre-op 69.3±30.0 59.54±12.36 0.06
Post-op 1.1±6.1 1.13±0.0 0.95
Sleep/energy
Pre-op 48.2±22.4 31.26±11.82 0.68
Post-op 4.0±11.4 10.68±6.93 0.50
Severity measures
Pre-op 42.8±20.0 28.84±11.35 0.19
Post-op 1.1±4.8 1.06±16.87 0.20
p=0.001* p=0.001*
Int Urogynecol J (2013) 24:1899–1907 1905
objective cure criteria [3, 20]. Also, the mesh anchoring
mechanism varies among the studies, with the armed
transobturator system used in some commercial kits. With
those, one may advocate that they are different procedures
and should not be equally compared.
We observed an absolute difference in the objective success
rate of around 26 % between the techniques, favoring the
mesh group. In a large multicenter trial involving 389 patients,
Altman and coworkers evaluated another trocar-guided
transvaginal synthetic mesh kit for anterior POP repair and
reported a 26 % point difference, which strengthens our find-
ings [21]. We estimate that the NNT is 4, meaning that one
POP recurrence is avoided in each 4 patients that receive mesh
augmentation for anterior compartment repair.
The literature analyses should also take into account other
relevant aspects such as POP stages, concomitant surgical pro-
cedures, and recurrent cases enrolled in each trial [3]. Thosemay
interferewith interpretation of the results. In this RCT,we strictly
included advanced anterior POP cases and the groups were
homogeneous regarding the most important demographic data
including the ones related to previous and associated surgeries.
However, our study involved primary as well as recurrent POP
and we were not able to statistically analyze them separately.
We had a 5 % rate of mesh extrusion, which is in agreement
with the range described in the literature (3–19 %) [5, 18, 21].
We postulate that the vaginal mucosa closure in an overlapping
fashionmay explain at least in part the low rate of extrusion, an
idea that must be a subject for further studies.
We observed better posterior compartment anatomical
findings (points Ap and Bp) as well as a higher rate of
dyspareunia in the AC group. Those may represent the results
of the additional posterior colporrhaphy repair that patients
from this group have received, even though this study in-
volved a limited number of participants making it difficult to
derive precise conclusions considering concomitant proce-
dures. Based on our results, it is interesting to note the lack
of apical support provided by this trocar-guided mesh kit, not
designed to treat associated advanced apical prolapse.
The International Continence Society considers POP-Q
stages 0 and I as anatomical success [22]. However, this
definition has been questioned when considering treatment
outcomes, since around two thirds of multiparous women
present with some degree of POP, and the majority are
asymptomatic [23]. Moreover, patients may not be aware
of prolapse stage II [24]. Therefore, cure criteria should be
more properly assessed by adding the evaluation of symp-
toms reported by the patients [5, 24]. In our study, we used
the validated condition-specific P-QOL questionnaire to
evaluate the patient’s bothersome symptoms related to
POP [17]. Both techniques used to repair anterior compart-
ment prolapse significantly improved postoperative quality
of life compared with preoperative status. No significant
differences were detected in the scores of all questionnaire
domains in the postoperative assessment between AC and
repair using mesh.
Our trial achieved high rates of follow-up. Some aspects
may have accounted for the treatment adherence: the small
number of participants, positive reinforcement by phone calls
throughout the trial, and the fact that our population is com-
posed of humble women who are dependent on the public
health system to receive good care.
In conclusion, our study demonstrated that transvaginal
synthetic mesh (Nazca TC™) for advanced anterior POP
repair is associated with a higher anatomical success rate of
the anterior compartment compared with AC using native
tissues. Quality of life equally improved after both techniques.
However, the trial failed to detect differences in subjective
cure rates, quality of life, or complication rates between the
groups at the 1-year follow-up. With that in mind, additional
studies involving a larger population and a longer follow-up
time are required to determine the role of the trocar-guided
synthetic mesh kits in pelvic floor reconstruction.
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